Segall Bryant & Hamill International Equity Fund - Retail Class CIQRX

Medalist Rating as of | See Segall Bryant & Hamill Investment Hub
  • NAV / 1-Day Return 16.51  /  +0.92 %
  • Total Assets 15.8M
  • Adj. Expense Ratio
    0.990%
  • Expense Ratio 1.040%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Foreign Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.16%
  • Turnover 107%

USD | NAV as of Sep 12, 2026 | 1-Day Return as of Sep 12, 2026, 12:25 AM GMT+0

Morningstar’s Analysis CIQRX

Will CIQRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Segall Bryant & Hamll Intl Eq Retl holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CIQRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 16.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Roche Holding AG Ordinary Shares new

2.38 350,583
Healthcare

ASML Holding NV

2.02 296,729
Technology

Banco Bilbao Vizcaya Argentaria SA

1.79 262,971
Financial Services

Novartis AG Registered Shares

1.69 248,531
Healthcare

BNP Paribas Act. Cat.A

1.65 242,528
Financial Services

UniCredit SpA

1.55 227,651
Financial Services

GSK PLC

1.49 218,495
Healthcare

NatWest Group PLC

1.40 206,559
Financial Services

Nomura Holdings Inc

1.22 178,902
Financial Services

Danske Bank AS

1.22 178,862
Financial Services

Sponsor Center